Extramedullary Plasmacytoma
📧 Sign up to get email alerts when something new happens for Extramedullary Plasmacytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease [Phase 2]
This update describes a Phase 2 trial evaluating a four-drug regimen (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) for mult…
-
CLINICAL_TRIALS research · 2015-01-13Clinical Trial Update: CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma [Phase 3]
A Phase 3 clinical trial is evaluating a CDD-based regimen with Bortezomib versus CDD alone in relapsed or refractory multiple myeloma with …